Literature DB >> 9184794

The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord.

A H Dickenson1, V Chapman, G M Green.   

Abstract

1. The aim of this review is to consider the relative roles of inhibitory and excitatory amino acid receptor-mediated events in the processes leading to pain transmission in the spinal cord. 2. Emphasis will be on the roles of the inhibitory and excitatory amino acids, GABA and glutamate, and how the relative balance between activity in these systems appears to determine the level of pain transmission. 3. The N-methyl-D-aspartate (NMDA) receptor for glutamate has been implicated in the generation and maintenance of central (spinal) states of hypersensitivity. It has been shown that activation of this receptor underlies wind-up, whereby the level of transmission of noxious messages is potentiated. Antagonists at this receptor-channel complex prevent or block enhanced (hyperalgesic) pain states induced by tissue damage, inflammation, nerve damage and ischemia. 4. Information concerning amplification systems in the spinal cord, such as the NMDA receptor, is a step toward understanding why and how a painful response is not always matched to the stimulus. Such events have parallels with other plastic events such as long-term potentiation (LTP) in the hippocampus. 5. However, the roles of inhibitory transmitter systems can also change insofar as opioid, adenosine and GABA transmission in the spinal cord can vary in different pain states. 6. Changes in GABA systems have been well-documented and discussion will center on whether this has clinical implications. 7. In addition to behavioral and electrophysiological approaches to the pharmacology of pain the current status of the use of markers of early onset genes such as c-fos, as monitors of activity, will be discussed. 8. Hyperalgesia would appear to be balanced by inhibitions during inflammatory conditions but not in neuropathic states, pains due to nerve damage. In the latter case, events reminiscent of LTP may predominate, whereas they are held in check by inhibitions under conditions of inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184794     DOI: 10.1016/s0306-3623(96)00359-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  70 in total

1.  In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system.

Authors:  M Tsuda; S Ueno; K Inoue
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 2.  Neuropharmacologic targets and agents in fibromyalgia.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Curr Pain Headache Rep       Date:  2002-08

3.  Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn.

Authors:  Beth K Rycroft; Kristina S Vikman; MacDonald J Christie
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

4.  Fibromyalgia: revisiting the literature.

Authors:  Diane Forbes; Andrew Chalmers
Journal:  J Can Chiropr Assoc       Date:  2004-06

Review 5.  Pain in ankylosing spondylitis: a neuro-immune collaboration.

Authors:  Katayoon Bidad; Eric Gracey; Kasey S Hemington; Josiane C S Mapplebeck; Karen D Davis; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 6.  Ionotropic glutamate receptors in spinal nociceptive processing.

Authors:  Max Larsson
Journal:  Mol Neurobiol       Date:  2009-10-31       Impact factor: 5.590

7.  Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite cells.

Authors:  Luiz Fernando Ferrari; Celina Monteiro Lotufo; Dionéia Araldi; Marcos A Rodrigues; Larissa P Macedo; Sérgio H Ferreira; Carlos Amilcar Parada
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Neovascularisation in chronic painful patellar tendinosis--promising results after sclerosing neovessels outside the tendon challenge the need for surgery.

Authors:  Håkan Alfredson; Lars Ohberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-11-26       Impact factor: 4.342

9.  A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study.

Authors:  Gábor Veres; Annamária Fejes-Szabó; Dénes Zádori; Gábor Nagy-Grócz; Anna M László; Attila Bajtai; István Mándity; Márton Szentirmai; Zsuzsanna Bohár; Klaudia Laborc; István Szatmári; Ferenc Fülöp; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2016-09-14       Impact factor: 3.575

10.  Midazolam administration reverses thermal hyperalgesia and prevents gamma-aminobutyric acid transporter loss in a rodent model of neuropathic pain.

Authors:  Andre Shih; Vjekoslav Miletic; Gordana Miletic; Lesley J Smith
Journal:  Anesth Analg       Date:  2008-04       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.